The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer

Purpose: DNA demethylating agents have shown clinical effectiveness in hematological and solid tumors. This trial tested the safety, efficacy, and treatment outcomes of decitabine-based chemotherapy or combined with immunotherapy in recurrent ovarian cancer patients. Patients and methods: Fifty-five...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Zhang, Yan, Mei, Qian, Liu, Yang, Li, Xiang, Brock, Malcolm V., Chen, Meixia, Dong, Liang, Shi, Lu, Wang, Yao, Guo, Mingzhou, Nie, Jing, Han, Weidong
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599090/
https://ncbi.nlm.nih.gov/pubmed/28932630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1323619
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados